THE SYSTEMIC IMPACT OF PERIODONTAL DISEASE: ASSOCIATIONS WITH DIABETES, ALZHEIMER'S, HYPERTENSION, KIDNEY DISEASE, AND GASTROINTESTINAL CONDITIONS
DOI:
https://doi.org/10.56238/arev7n8-055Keywords:
Periodontal Disease, Diabetes, Alzheimer's, Hypertension, Kidney Disease, Gastrointestinal ConditionsAbstract
Objective: This narrative literature review aims to explore the associations between periodontal disease and systemic conditions such as diabetes mellitus, Alzheimer’s disease, hypertension, kidney disease, and gastrointestinal disorders.
Methodology: A comprehensive search was conducted across major databases including PubMed, Cochrane Library, EMBASE, and Google Scholar. Keywords used were “Periodontal Disease,” “Diabetes,” “Alzheimer’s,” “Hypertension,” “Kidney Disease,” and “Gastrointestinal Conditions,” combined using Boolean operators “AND” and “OR.” The selection process involved three stages: removal of duplicates using Zotero, screening of titles and abstracts, and full-text analysis. Only articles relevant to the review’s objective were included.
Results: The reviewed studies revealed strong correlations between periodontal disease and systemic conditions. In diabetes, periodontal inflammation exacerbates glycemic control. In Alzheimer’s disease, periodontal pathogens may contribute to neuroinflammation. Associations with hypertension, chronic kidney disease, and gastrointestinal conditions such as inflammatory bowel disease were also identified, suggesting that periodontal inflammation may play a contributory role through systemic inflammatory pathways.
Conclusion: Periodontal disease extends beyond the oral cavity and may influence or be influenced by systemic health. Understanding these connections emphasizes the importance of oral health in the broader context of general health and supports integrated, interdisciplinary care.
Downloads
References
Atarashi K, Tanoue T, Shima T, et al. Oral immune tolerance induction by colonic dendritic cells. Nature. 2017;550(7674):447–451.
Chapple IL, Genco RJ. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40(Suppl 14):S106–S112. DOI: https://doi.org/10.1111/jcpe.12077
Chen CK, Wu YT, Chang YC. Association between chronic periodontitis and the risk of Alzheimer's disease: a retrospective, population-based, matched-cohort study. Alzheimers Res Ther. 2017;9(1):56. DOI: https://doi.org/10.1186/s13195-017-0282-6
Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5(1):eaau3333.
Fisher MA, Taylor GW. A prediction model for chronic kidney disease includes periodontal disease. J Periodontol. 2009;80(1):16–23. DOI: https://doi.org/10.1902/jop.2009.080226
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30–44. DOI: https://doi.org/10.1038/nri3785
Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10(10):717–725. DOI: https://doi.org/10.1038/nrmicro2873
How KY, Song KP, Chan KG. Porphyromonas gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line. Front Microbiol. 2016;7:53. DOI: https://doi.org/10.3389/fmicb.2016.00053
Kamer AR, Pirraglia E, Tsui W, et al. Periodontal disease associates with higher brain amyloid load in normal elderly. Neurobiol Aging. 2020;82:120–127.
Kitamoto S, Nagao-Kitamoto H, Jiao Y, et al. The inter-kingdom interaction between P. gingivalis and Candida albicans exacerbates oral infection. PLoS Pathog. 2020;16(5):e1008664.
Kshirsagar AV, Craig RG, Beck JD, et al. Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2007;49(5):596–603.
Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000;13(4):547–558. DOI: https://doi.org/10.1128/CMR.13.4.547
Munoz Aguilera E, Suvan J, Buti J, et al. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc Res. 2020;116(1):28–39. DOI: https://doi.org/10.1093/cvr/cvz201
Preshaw PM, Alba AL, Herrera D, et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55(1):21–31. DOI: https://doi.org/10.1007/s00125-011-2342-y
Ricardo AC, Athavale A, Chen J, et al. Periodontal disease, chronic kidney disease and mortality: results from the Third National Health and Nutrition Examination Survey. BMC Nephrol. 2015;16:97. DOI: https://doi.org/10.1186/s12882-015-0101-x
Rother ET. Revisão sistemática x revisão narrativa. Acta Paul Enferm. 2007;20(2):5–6. DOI: https://doi.org/10.1590/S0103-21002007000200001
Schmidt TS, Raes J, Bork P. The human gut microbiome: from association to modulation. Cell. 2019;172(6):1198–1215. DOI: https://doi.org/10.1016/j.cell.2018.02.044
Teeuw WJ, Gerdes VE, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. J Clin Periodontol. 2010;37(12):1110–1116.
Tonetti MS, Van Dyke TE. Periodontitis and atherosclerotic cardiovascular disease: Consensus report of the Joint EFP/AAP Workshop. J Clin Periodontol. 2013;40(Suppl 14):S24–S29. DOI: https://doi.org/10.1111/jcpe.12089
Vidal F, Figueredo CM, Cordovil I, Fischer RG. Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol. 2020;91(4):519–530.
